Ligand Pharmaceuticals received FDA approval for its drug Filspari and was listed on the Nasdaq stock exchange.

The entities involved

• Ligand Pharmaceuticals →

  biopharmaceutical company based out of La Jolla, California

  • Ligand Pharmaceuticals filed a transaction with the SEC, while Royal Bank of Canada lifted its target price, and the stock is listed on Nasdaq.Wed 13:17
• FDA →
  • FDA granted Fast Track designation to SAB-142 on November 1, 2026.07:01
  • The FDA provided funding for the new vessel M/V Captain Dinsmore in May 2026.05:39
• Nasdaq →

  American fully electronic stock exchange

  • GT Biopharma filed with the SEC regarding institutional investment, and its stock traded on the Nasdaq exchange.06:59
  • Tim Chen led a company through a strategic inflection point and listed on the electronic stock exchange, Nasdaq.06:41

Related events

• Merck announced on September 3, 2025, that it is seeking potential approval for new drugs from the FDA.Jun 7
• FDA granted accelerated approval for VOCERYQ, causing INOVIO stock to lead Nasdaq gainers.Mon 19:33